Drug
Cdx1127
Cdx1127: highest development phase Phase 1, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX1127 NCT02284971 | Phase 1 | Prostatic Neoplasms |
Latest
No recent events.
Follow Cdx1127 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.